Roland Baron

Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium.

Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France.

Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.

Part of Kirin Holdings Co., Ltd., ProStrakan, Inc. develops, manufactures, and distributes prescription medicines. The company is based in Bridgewater, NJ.

The American Society for Bone & Mineral Research engages in bone, mineral and musculoskeletal research. The non-profit company is based in Washington.